Purchase Order 36C24225P0967
Award Date
5/8/25
Potential Completion Date
5/8/25
Potential Value
$13K
Federal Agency
Veterans Integrated Service Network 2
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Belle Isle, FL 32809, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a firm fixed price purchase order contract to Walgreens Specialty Pharmacy, LLC to provide the branded medication Jynarque 45mg/15mg to the Northport VA Medical Center. The contract has a potential value of $12,580.72 and a period of performance through May 7, 2024. No set-aside designation was used for this contract. As the prime contractor, Walgreens Specialty Pharmacy will rapidly deliver this specialty...
This is a $13,242.99 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) to the VA's Veterans Integrated Service Network 2 (VISN 2). The award has no set-aside designation, indicating it is open to all qualified vendors. The performance period runs from the award date of April 30, 2025 through the...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC for the delivery of the specialty medication JYNARQUE. The $112,212.00 contract has a completion date of September 30, 2022. As the prime contractor, Walgreens Specialty Pharmacy will provide the medication to VHA pharmacies across multiple Veterans Integrated Service Networks, including Networks 2, 6, 9, 12, 20, 21, and 22, to...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, a for-profit organization, to provide the specialty pharmaceutical product JYNARQUE to the Puget Sound VA Health Care System (VAHCS). The contract has a potential value of $312,685.57 and a period of performance through September 30, 2023. No set-aside designation was used for this award. Walgreens Specialty Pharmacy,...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order contract to Walgreens Specialty Pharmacy, LLC to provide the specialty drug Jynarque. The $127,463.19 contract has a completion date of September 30, 2022 and was awarded on October 1, 2021. The contract is to deliver the medication to VHA facilities across multiple Veterans Integrated Service Networks, with performance primarily occurring at Walgreens' locations in...
Walgreens Specialty Pharmacy, LLC was awarded a firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The $12,580.72 contract is to deliver Jynarque 45MG/15MG tablets to Belle Isle, Florida by June 11, 2024. As the prime contractor, Walgreens Specialty Pharmacy will fulfill this order for the specified medication to support healthcare services for veterans within VISN 2. No set aside was used and no...
Walgreens Specialty Pharmacy, LLC was awarded a $11,425.69 firm fixed price purchase order as the prime contractor to supply Jynarque 45MG/15MG tablets to the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 2. Performance will occur at Walgreens' location in Pittsburgh, Pennsylvania. As a specialty pharmacy, Walgreens will fulfill this non-set aside contract to rapidly provide the branded medication to VHA pharmacies in Network 2 in support...
This federal contract award, valued at $12,580.72, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain. The contract is for the delivery of the specialized pharmaceutical product Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is a firm fixed-price purchase order contract with a period of performance ending...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration, specifically the Veterans Integrated Service Network (VISN) 2, to Walgreens Specialty Pharmacy, LLC. The contract is for the delivery of the medication Jynarque (tolvaptan) 45/15mg tablets, which is used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $13,242.99 and a performance period ending on June 18, 2025. The...
This federal contract award, valued at $12,580.72, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to the prime contractor, Walgreens Specialty Pharmacy, LLC (doing business as Walgreens). The contract is for the delivery of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is a firm fixed-price purchase order with a completion date of February 13, 2025. Walgreens Specialty...